TRAVATAN Z® (travoprost ophthalmic solution) 0.004% is used to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who may be intolerant to other intraocular pressure lowering medications or for whom other medications do not sufficiently lower IOP. TRAVATAN Z® solution is our most recent formulation that replaces benzalkonium chloride (BAK) with SOFZIA®, an ionic buffered preservative system.
TRAVATAN Z® solution should not be administered while wearing contact lenses. Patients should not touch the bottle tip to any surface to avoid the risk of contamination.
This product should not be taken by those with a sensitivity or allergy to its ingredients. Safety and efficacy have not been determined in children. Caution should be used when administering this drug to pregnant or nursing women. The most common side effect of TRAVATAN Z® solution is red eyes, but patients may also experience decreased visual acuity, eye pain and blurred vision, as well as other effects. If you experience any of these symptoms contact your doctor. Prostaglandins, such as TRAVATAN Z® solution, have been known to cause changes in eye color and eye lid skin color, as well as changes in eye lashes, which may be permanent. For full U.S. prescribing information, see the product insert below.